Eli Lilly and Company

Pharmareferent CMH (m/w/d) Gebiet 312205: Pforzheim, Sindelfingen, Böblingen, Calw, Nagold, Herrenberg, Horb

Germany

Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a scientific education, ideally a university degree, or be a certified pharmaceutical representative. A minimum of 4 years of experience as a successful pharmaceutical representative is required, with specific knowledge in the diabetes field. Proven clinical experience, strong sales ambitions, excellent sales skills, and prior sales experience in diabetes are essential. The ability to think and act independently, particularly in customer and territory management, along with high social competence and teamwork skills, are necessary. Candidates should also have reliable and trustworthy work habits, solid English language skills, and good knowledge of MS Office (Word, Excel, PowerPoint) and Outlook.

Responsibilities

The Pharmaceutical Representative will conduct sales discussions with medical professionals, including specialists, clinic physicians, pharmacists, and nursing staff. They will implement sales and marketing strategies for the business unit, develop and execute territorial action plans, and manage events. Additionally, the role involves organizing and conducting further training sessions for specialist and patient groups.

Skills

Sales
Marketing
Event Management
Medical Education
Diabetes
Clinical Experience
Sales Skills
Customer Relationship Management
MS Office
English

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI